KUNLUN CAPITAL
Kunlun Capital is a value-oriented and fundamentally driven family office. We do not manage external funds.
KUNLUN CAPITAL
Status:
Active
Contact:
+65 6100 5865
Email Addresses:
[email protected]
Technology used in webpage:
SPF SSL By Default Microsoft Exchange Online Office 365 Mail CPanel SSL LiteSpeed QUIC DNS Made Easy DNS
Similar Organizations
Bravia Capital
Bravia Capital is a global investment firm.
FutureX Capital
FutureX Capital is an investment firm.
KB Investment
KB Investment is one of Korea’s leading investment firms.
Kingsway Capital
Kingsway Capital is a investment management firm.
Round Hill Capital
Round Hill Capital is an investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-12 | Hui-Gene Therapeutics | Kunlun Capital investment in Series C - Hui-Gene Therapeutics | N/A |
| 2022-04-19 | Ningbo Shanshan | Kunlun Capital investment in Post-IPO Equity - Ningbo Shanshan | 3.05 B CNY |
| 2022-03-29 | CellOrigin Biotech | Kunlun Capital investment in Venture Round - CellOrigin Biotech | 100 M CNY |
| 2022-03-14 | UniXell | Kunlun Capital investment in Seed Round - UniXell | 200 M CNY |
| 2022-03-14 | Nutshell Therapeutics | Kunlun Capital investment in Series A - Nutshell Therapeutics | 40 M USD |
| 2021-12-21 | Zhongke Digital | Kunlun Capital investment in Series A - Zhongke Digital | N/A |
| 2021-12-16 | Circular Code Biology | Kunlun Capital investment in Seed Round - Circular Code Biology | 20 M USD |
| 2021-12-16 | CirCode | Kunlun Capital investment in Seed Round - CirCode | 20 M USD |
| 2021-10-14 | Danwang Medical | Kunlun Capital investment in Series A - Danwang Medical | 120 M CNY |
| 2021-08-01 | UniXell | Kunlun Capital investment in Angel Round - UniXell | N/A |